Free Trial

Pro-Dex (PDEX) Competitors

Pro-Dex logo
$49.43 -0.39 (-0.78%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$49.32 -0.12 (-0.23%)
As of 07/25/2025 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PDEX vs. BBNX, EMBC, SMLR, CBLL, KIDS, AVNS, BVS, AXGN, BFLY, and DCTH

Should you be buying Pro-Dex stock or one of its competitors? The main competitors of Pro-Dex include Beta Bionics (BBNX), Embecta (EMBC), Semler Scientific (SMLR), CeriBell (CBLL), OrthoPediatrics (KIDS), AVANOS MEDICAL (AVNS), Bioventus (BVS), AxoGen (AXGN), Butterfly Network (BFLY), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry.

Pro-Dex vs. Its Competitors

Pro-Dex (NASDAQ:PDEX) and Beta Bionics (NASDAQ:BBNX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings, media sentiment and analyst recommendations.

In the previous week, Beta Bionics had 6 more articles in the media than Pro-Dex. MarketBeat recorded 7 mentions for Beta Bionics and 1 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 1.87 beat Beta Bionics' score of 0.86 indicating that Pro-Dex is being referred to more favorably in the media.

Company Overall Sentiment
Pro-Dex Very Positive
Beta Bionics Positive

Pro-Dex has a net margin of 14.61% compared to Beta Bionics' net margin of 0.00%. Pro-Dex's return on equity of 29.08% beat Beta Bionics' return on equity.

Company Net Margins Return on Equity Return on Assets
Pro-Dex14.61% 29.08% 16.19%
Beta Bionics N/A N/A N/A

15.3% of Pro-Dex shares are owned by institutional investors. 47.5% of Pro-Dex shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Pro-Dex presently has a consensus price target of $56.00, indicating a potential upside of 13.29%. Beta Bionics has a consensus price target of $23.44, indicating a potential upside of 57.98%. Given Beta Bionics' higher possible upside, analysts plainly believe Beta Bionics is more favorable than Pro-Dex.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pro-Dex
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Beta Bionics
0 Sell rating(s)
4 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.75

Pro-Dex has higher earnings, but lower revenue than Beta Bionics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pro-Dex$53.84M2.99$2.13M$2.8017.65
Beta Bionics$65.12M9.88-$54.76MN/AN/A

Summary

Pro-Dex beats Beta Bionics on 8 of the 14 factors compared between the two stocks.

Get Pro-Dex News Delivered to You Automatically

Sign up to receive the latest news and ratings for PDEX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PDEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PDEX vs. The Competition

MetricPro-DexMED/DENTAL IndustryMedical SectorNASDAQ Exchange
Market Cap$162.46M$15.92B$5.70B$9.50B
Dividend YieldN/A1.41%4.69%4.01%
P/E Ratio17.6518.9528.1020.06
Price / Sales2.992.46428.7189.10
Price / Cash52.0317.9036.2258.56
Price / Book5.474.008.665.87
Net Income$2.13M$430.42M$3.25B$258.55M
7 Day Performance7.01%5.58%4.22%3.73%
1 Month Performance14.66%5.17%10.51%11.75%
1 Year Performance163.07%23.10%34.40%18.02%

Pro-Dex Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PDEX
Pro-Dex
2.4778 of 5 stars
$49.43
-0.8%
$56.00
+13.3%
+159.1%$162.46M$53.84M17.65140Positive News
BBNX
Beta Bionics
N/A$14.30
+5.2%
$23.44
+63.9%
N/A$589.21M$65.12M0.00294News Coverage
Lockup Expiration
EMBC
Embecta
4.6895 of 5 stars
$10.29
+5.2%
$19.00
+84.6%
-26.1%$571.57M$1.12B11.432,100
SMLR
Semler Scientific
3.3002 of 5 stars
$39.67
-3.8%
$89.00
+124.4%
+18.5%$568.63M$56.29M-15.20120
CBLL
CeriBell
2.3135 of 5 stars
$15.21
-2.4%
$32.14
+111.3%
N/A$563.11M$65.44M0.00N/A
KIDS
OrthoPediatrics
4.1988 of 5 stars
$21.88
-0.6%
$35.83
+63.8%
-30.8%$534.55M$204.73M-12.50200
AVNS
AVANOS MEDICAL
2.9121 of 5 stars
$11.40
+1.6%
N/A-47.6%$518.86M$687.80M-1.362,227News Coverage
BVS
Bioventus
3.3542 of 5 stars
$6.30
+0.6%
$13.75
+118.3%
-11.8%$517.51M$567.70M-10.331,200
AXGN
AxoGen
2.219 of 5 stars
$11.61
+2.9%
$24.50
+111.0%
+43.3%$513.74M$194.52M-77.39450
BFLY
Butterfly Network
2.4812 of 5 stars
$1.89
+0.8%
$3.50
+85.7%
+85.4%$462.43M$82.06M-6.50460News Coverage
Upcoming Earnings
DCTH
Delcath Systems
2.7676 of 5 stars
$11.32
+0.6%
$24.00
+112.0%
+31.1%$391.80M$37.21M-22.6460News Coverage

Related Companies and Tools


This page (NASDAQ:PDEX) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners